HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lentigo (Lentiginosis)

Small circumscribed melanoses resembling, but differing histologically from, freckles. The concept includes senile lentigo ('liver spots') and nevoid lentigo (nevus spilus, lentigo simplex) and may also occur in association with multiple congenital defects or congenital syndromes (e.g., Peutz-Jeghers syndrome).
Also Known As:
Lentiginosis; Lentigines; Lentiginoses; Lentigos
Networked: 483 relevant articles (77 outcomes, 64 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Hyperpigmentation
2. Melanosis (Freckles)
3. Actinic Keratosis
4. Seborrheic Keratosis
5. Psoriasis (Pustulosis Palmaris et Plantaris)

Experts

1. Imokawa, Genji: 7 articles (07/2019 - 04/2004)
2. Chang, Sung Eun: 5 articles (02/2021 - 01/2015)
3. Kang, Hee Young: 5 articles (01/2018 - 01/2009)
4. Ortonne, Jean-Paul: 5 articles (12/2011 - 05/2006)
5. Stratakis, Constantine A: 4 articles (11/2022 - 04/2007)
6. Vachiramon, Vasanop: 4 articles (10/2022 - 04/2016)
7. Passeron, T: 4 articles (07/2020 - 11/2012)
8. Zouboulis, C C: 4 articles (07/2020 - 07/2000)
9. Chan, Henry H: 4 articles (12/2011 - 07/2002)
10. Kawada, Akira: 4 articles (11/2011 - 06/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lentigo:
1. Tretinoin (Retinoic Acid)FDA LinkGeneric
2. hydroquinone (Esoterica)FDA Link
3. SolutionsIBA
4. mequinolFDA Link
5. tazarotene (Tazorac)FDA Link
04/01/2004 - "At week 24, when compared to vehicle, tazarotene resulted in a significantly greater incidence of patients achieving treatment success (over 50 percent greater improvement) and at least a 1 grade improvement in fine wrinkling, mottled pigmentation, pore size, lentigines, elastosis, irregular depigmentation, tactile roughness, coarse wrinkling and overall integrated assessment of photodamage. "
11/01/2002 - "Compared with the vehicle, at week 24 tazarotene resulted in a significantly greater incidence of patients achieving treatment success (>or=50% global improvement) and at least a 1-grade improvement in fine wrinkling, mottled hyperpigmentation, lentigines, elastosis, pore size, irregular depigmentation, tactile roughness, coarse wrinkling, and the overall integrated assessment of photodamage (P<.01). "
02/01/2005 - "Tazarotene cream was significantly more effective than vehicle in reducing fine wrinkles, mottled hyperpigmentation, lentigines, irregular depigmentation, apparent pore size, elastosis, tactile roughness, and an overall integrated assessment of photodamage. "
01/01/2014 - "Tazarotene cream 0.1% (TAZ) is a United States Food and Drug Administration-approved drug indicated for use in the mitigation of facial fine wrinkling, facial mottled hyper- and hypopigmentation, and benign facial lentigines when taken in conjunction with a comprehensive skin care and sun avoidance program. "
03/01/2013 - "Tazarotene is also used as adjunctive treatment for specified clinical manifestations of chronically photodamaged skin (facial fine wrinkling, mottled facial hypopigmentation and hyperpigmentation, and benign facial lentigines), along with comprehensive skin care and photoprotection from sunlight. "
6. Melanins (Melanin)IBA
7. Adapalene (Differin)FDA LinkGeneric
8. Trichloroacetic AcidIBA
9. glycolic acid (glycolate)IBA
10. Sunscreening Agents (Sunscreens)IBA
01/01/1995 - "Acquired persistent atypical lentigines as a failure of 5-methoxypsoralen-containing sunscreens in the photochemoprotection from ultraviolet-radiation-induced damage."
03/01/2019 - "A randomized, uncontrolled and investigator-blinded, single-center study enrolled adult men and women (18-45 years) with Fitzpatrick skin phototypes IV (28° < individual typological angle <10°) and V (10° < individual typological angle < -30°) with pigmentary abnormalities seen on the face in adults (actinic lentigines and postinflammatory hyperpigmentation), who did not use sunscreens. "
08/11/2022 - "The presence of actinic damage, in the form of solar lentigines, actinic keratoses, and basal and squamous cell carcinomas, was recorded in both groups, together with sunscreen use. "
04/01/2003 - "The purpose of this open-label study was to determine the adverse event rate of topical 4HA/tretinoin when used twice daily for up to 24 weeks with concomitant sunscreen in the treatment of solar lentigines and related hyperpigmented lesions. "
04/01/2012 - "A series of eight case studies were conducted to evaluate the efficacy and tolerability of a novel treatment regimen combining one in-office superficial chemical peel procedure followed by a 12-week topical maintenance program consisting of micro-entrapped 4% hydroquinone, tri-retinol, and sunscreen with sun protection factor (SPF) 30+. Patients presented with Fitzpatrick skin types II and III and mild-to-moderate solar lentigines and/or melasma on their facial skin. "

Therapies and Procedures

1. Lasers (Laser)
2. Solid-State Lasers
3. Therapeutics
4. Cryotherapy (Therapy, Cold)
5. Gas Lasers